Marinus Pharmaceuticals Inc (MRNS)
1.42
-0.02
(-1.39%)
USD |
NASDAQ |
Apr 25, 16:00
1.425
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Market Cap: 78.00M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 78.00M |
| April 24, 2024 | 79.10M |
| April 23, 2024 | 79.10M |
| April 22, 2024 | 81.02M |
| April 19, 2024 | 75.80M |
| April 18, 2024 | 77.45M |
| April 17, 2024 | 79.10M |
| April 16, 2024 | 65.92M |
| April 15, 2024 | 71.41M |
| April 12, 2024 | 413.08M |
| April 11, 2024 | 435.05M |
| April 10, 2024 | 444.39M |
| April 09, 2024 | 460.32M |
| April 08, 2024 | 450.43M |
| April 05, 2024 | 428.46M |
| April 04, 2024 | 476.80M |
| April 03, 2024 | 477.90M |
| April 02, 2024 | 487.24M |
| April 01, 2024 | 492.73M |
| March 28, 2024 | 493.97M |
| March 27, 2024 | 483.59M |
| March 26, 2024 | 480.31M |
| March 25, 2024 | 487.96M |
| March 22, 2024 | 481.40M |
| March 21, 2024 | 492.33M |
| Date | Value |
|---|---|
| March 20, 2024 | 493.97M |
| March 19, 2024 | 508.18M |
| March 18, 2024 | 492.88M |
| March 15, 2024 | 513.09M |
| March 14, 2024 | 489.05M |
| March 13, 2024 | 515.83M |
| March 12, 2024 | 507.08M |
| March 11, 2024 | 463.37M |
| March 08, 2024 | 483.59M |
| March 07, 2024 | 478.12M |
| March 06, 2024 | 493.42M |
| March 05, 2024 | 504.90M |
| March 04, 2024 | 521.29M |
| March 01, 2024 | 542.05M |
| February 29, 2024 | 519.10M |
| February 28, 2024 | 538.36M |
| February 27, 2024 | 546.00M |
| February 26, 2024 | 545.45M |
| February 23, 2024 | 533.44M |
| February 22, 2024 | 525.25M |
| February 21, 2024 | 532.35M |
| February 20, 2024 | 520.88M |
| February 16, 2024 | 543.82M |
| February 15, 2024 | 546.00M |
| February 14, 2024 | 546.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.10M
Minimum
Jul 24 2019
705.19M
Maximum
Jun 24 2021
335.77M
Average
340.80M
Median
Market Cap Benchmarks
| Nektar Therapeutics | 242.38M |
| DiaMedica Therapeutics Inc | 96.03M |
| Ligand Pharmaceuticals Inc | 1.246B |
| Soligenix Inc | 4.494M |
| Macrogenics Inc | 897.15M |
Market Cap Related Metrics
| PS Ratio | 2.462 |
| PEG Ratio | -0.0011 |
| Price to Book Value | 4.653 |
| Price | 1.42 |
| Earnings Yield | -185.2% |
| PEGY Ratio | -0.0011 |